Expression cloning and signaling properties of the rat glucagon receptor
- PMID: 8384375
- DOI: 10.1126/science.8384375
Expression cloning and signaling properties of the rat glucagon receptor
Abstract
Glucagon and the glucagon receptor are a primary source of control over blood glucose concentrations and are especially important to studies of diabetes in which the loss of control over blood glucose concentrations clinically defines the disease. A complementary DNA clone for the glucagon receptor was isolated by an expression cloning strategy, and the receptor protein was expressed in several kidney cell lines. The cloned receptor bound glucagon and caused an increase in the intracellular concentration of adenosine 3', 5'-monophosphate (cAMP). The cloned glucagon receptor also transduced a signal that led to an increased concentration of intracellular calcium. The glucagon receptor is similar to the calcitonin and parathyroid hormone receptors. It can transduce signals leading to the accumulation of two different second messengers, cAMP and calcium.
Similar articles
-
Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor.Endocrinology. 1997 Jun;138(6):2640-3. doi: 10.1210/endo.138.6.9104. Endocrinology. 1997. PMID: 9165060
-
Signal transduction by the cloned glucagon-like peptide-1 receptor: comparison with signaling by the endogenous receptors of beta cell lines.Mol Pharmacol. 1994 May;45(5):1029-35. Mol Pharmacol. 1994. PMID: 8190093
-
Point mutations in the first and third intracellular loops of the glucagon-like peptide-1 receptor alter intracellular signaling.Biochem Biophys Res Commun. 1996 Jun 25;223(3):624-32. doi: 10.1006/bbrc.1996.0945. Biochem Biophys Res Commun. 1996. PMID: 8687446
-
International Union of Pharmacology. XXXV. The glucagon receptor family.Pharmacol Rev. 2003 Mar;55(1):167-94. doi: 10.1124/pr.55.1.6. Pharmacol Rev. 2003. PMID: 12615957 Review.
-
The glucagon receptor: structural analysis by covalent labeling techniques.Pharmacol Ther. 1988;37(1):151-65. doi: 10.1016/0163-7258(88)90023-x. Pharmacol Ther. 1988. PMID: 2837791 Review. No abstract available.
Cited by
-
Class B1 GPCRs: insights into multireceptor pharmacology for the treatment of metabolic disease.Am J Physiol Endocrinol Metab. 2024 Nov 1;327(5):E600-E615. doi: 10.1152/ajpendo.00371.2023. Epub 2024 Jul 10. Am J Physiol Endocrinol Metab. 2024. PMID: 38984948 Free PMC article. Review.
-
Uniform trehalose nanogels for glucagon stabilization.RSC Appl Polym. 2024 Mar 13;2(3):473-482. doi: 10.1039/d3lp00226h. eCollection 2024 May 23. RSC Appl Polym. 2024. PMID: 38800515 Free PMC article.
-
Incretin and glucagon receptor polypharmacology in chronic kidney disease.Am J Physiol Endocrinol Metab. 2024 Jun 1;326(6):E747-E766. doi: 10.1152/ajpendo.00374.2023. Epub 2024 Mar 13. Am J Physiol Endocrinol Metab. 2024. PMID: 38477666 Free PMC article. Review.
-
Distinct physiological characteristics and altered glucagon signaling in GHRH knockout mice: Implications for longevity.Aging Cell. 2023 Dec;22(12):e13985. doi: 10.1111/acel.13985. Epub 2023 Sep 4. Aging Cell. 2023. PMID: 37667562 Free PMC article.
-
Glucagon and Its Receptors in the Mammalian Heart.Int J Mol Sci. 2023 Aug 15;24(16):12829. doi: 10.3390/ijms241612829. Int J Mol Sci. 2023. PMID: 37629010 Free PMC article. Review.
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
